Furthermore, there were significant correlations between the high level of NF-κB-p65, CXCR4 expression, clinical metastasis and INSS stages, which indicated the utility of NF-κB and CXCR4 as predictive biomarkers and therapeutic targets in neuroblastoma. The gene discussed is RELA; the disease is neuroblastoma.